Biosafe General Membership Meeting April 10, 2011

BIO’s Preclinical Safety Committee (BioSafe) will hold its annual general membership meeting. This meeting is open to BIO membership engaged in the conduct and reporting of preclinical safety evaluation for biopharmaceuticals. The meeting aims to ensure a common understanding and continued application of scientific principles with respect to key issues in the preclinical safety evaluation of biopharmaceuticals. BioSafe aims to serve as a resource for BIO members by identifying and responding to key scientific and regulatory issues related to the preclinical safety evaluation of biopharmaceutical products.

Patricia Ryan will present on "Species Selection for MEDI-565, a novel CEA/CD3-bispecific single-chain BiTE antibody."